Earnings ·
Dr. Reddy's Laboratories Limited reported for the quarter ended June 30, 2026, with revenues of Rs. 80,705 million…
RDYDR Reddys Laboratories Ltd
Dr. Reddy's Laboratories Limited reported for the quarter ended June 30, 2026, with revenues of Rs. 80,705 million (U.S.$ 853 million) compared to Rs. 85,452 million in the same period of the previous year. Net profit for the period was Rs. 4,348 million (U.S.$ 46 million), resulting in a diluted earnings per share (EPS) earnings per share of Rs. 5.32. Dr. Reddy's Laboratories Limited is a pharmaceutical company that develops and commercializes pharmaceutical products.